Steve Oh

1.6k total citations
20 papers, 1.1k citations indexed

About

Steve Oh is a scholar working on Molecular Biology, Biomedical Engineering and Surgery. According to data from OpenAlex, Steve Oh has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Biomedical Engineering and 5 papers in Surgery. Recurrent topics in Steve Oh's work include Pluripotent Stem Cells Research (13 papers), CRISPR and Genetic Engineering (7 papers) and 3D Printing in Biomedical Research (6 papers). Steve Oh is often cited by papers focused on Pluripotent Stem Cells Research (13 papers), CRISPR and Genetic Engineering (7 papers) and 3D Printing in Biomedical Research (6 papers). Steve Oh collaborates with scholars based in Singapore, United States and Israel. Steve Oh's co-authors include Andre Choo, Shaul Reuveny, Angela Chin, Miranda G.S. Yap, Allen K. Chen, Wey Jia Fong, Heng Liang Tan, Sherwin Ting, Allen Chen and Jon A. Rowley and has published in prestigious journals such as Stem Cells, Biotechnology and Bioengineering and PLoS Computational Biology.

In The Last Decade

Steve Oh

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Oh Singapore 15 827 550 354 120 99 20 1.1k
Zijun Zhang China 17 788 1.0× 241 0.4× 222 0.6× 218 1.8× 43 0.4× 52 1.4k
Haishuang Lin China 21 567 0.7× 257 0.5× 133 0.4× 54 0.5× 51 0.5× 36 921
Rumi Sawada Japan 13 361 0.4× 162 0.3× 150 0.4× 205 1.7× 73 0.7× 33 722
Benjamin E. Mead United States 8 387 0.5× 441 0.8× 122 0.3× 42 0.3× 35 0.4× 10 818
Briana R. Dye United States 12 742 0.9× 475 0.9× 501 1.4× 33 0.3× 48 0.5× 13 1.4k
Calvin C. Sheng United States 10 524 0.6× 217 0.4× 267 0.8× 49 0.4× 17 0.2× 18 894
Chukwuma A. Agu United Kingdom 6 373 0.5× 233 0.4× 139 0.4× 25 0.2× 34 0.3× 7 640
Iwona Grabowska Poland 17 550 0.7× 100 0.2× 250 0.7× 185 1.5× 78 0.8× 46 788
Daniel W. Youngstrom United States 14 269 0.3× 120 0.2× 227 0.6× 46 0.4× 107 1.1× 28 693
Maryam Niapour Canada 7 920 1.1× 208 0.4× 479 1.4× 38 0.3× 30 0.3× 8 1.1k

Countries citing papers authored by Steve Oh

Since Specialization
Citations

This map shows the geographic impact of Steve Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Oh more than expected).

Fields of papers citing papers by Steve Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Oh. The network helps show where Steve Oh may publish in the future.

Co-authorship network of co-authors of Steve Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Oh. A scholar is included among the top collaborators of Steve Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Oh. Steve Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fink, John K., et al.. (2022). Impact considerations of post-production processes on cell and gene drug products. Cytotherapy. 24(6). 583–589. 2 indexed citations
2.
Liu, Yang, Lu Yin, Steve Oh, & G. J. Conduit. (2020). Machine learning to predict mesenchymal stem cell efficacy for cartilage repair. PLoS Computational Biology. 16(10). e1008275–e1008275. 23 indexed citations
3.
Chen, Hongyu, Bin Yang, Alan Tin‐Lun Lam, et al.. (2018). Defined Serum‐Free Medium for Bioreactor Culture of an Immortalized Human Erythroblast Cell Line. Biotechnology Journal. 13(4). e1700567–e1700567. 15 indexed citations
4.
Lim, Jungeun, et al.. (2016). Expansion of Fetal Human Mesenchymal Stem Cells in Microcarrier-Spinner Cultures Improves their Chondrogenic Potential. Cytotherapy. 18(6). 1–1. 1 indexed citations
5.
Lee, Eugine, et al.. (2016). Superior Red Blood Cell Generation From Human Pluripotent Stem Cells via a Novel Microcarrier Based Embryoid Body Platform. Cytotherapy. 18(6). S41–S42. 1 indexed citations
6.
Chen, Allen, et al.. (2014). Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells. Stem Cell Research & Therapy. 5(1). 12–12. 37 indexed citations
7.
Chen, Allen K., Shunhui Wei, Weiping Han, et al.. (2012). Microcarrier Suspension Cultures for High-Density Expansion and Differentiation of Human Pluripotent Stem Cells to Neural Progenitor Cells. Tissue Engineering Part C Methods. 19(2). 166–180. 85 indexed citations
8.
Clarke, Dominic, Jon A. Rowley, Michael McCaman, et al.. (2012). Managing particulates in cellular therapy. Cytotherapy. 14(9). 1032–1040. 10 indexed citations
9.
Rowley, Jon A., Eytan Abraham, Andrew Campbell, Harvey Brandwein, & Steve Oh. (2012). Meeting Lot-Size Challenges of Manufacturing Adherent Cells for Therapy. 115 indexed citations
10.
Chen, Allen, et al.. (2010). Agitation can Induce Differentiation of Human Pluripotent Stem Cells in Microcarrier Cultures. Tissue Engineering Part C Methods. 17(2). 165–172. 82 indexed citations
11.
Lecina, Martí, Sherwin Ting, Andre Choo, Shaul Reuveny, & Steve Oh. (2010). Scalable Platform for Human Embryonic Stem Cell Differentiation to Cardiomyocytes in Suspended Microcarrier Cultures. Tissue Engineering Part C Methods. 16(6). 1609–1619. 88 indexed citations
12.
Oh, Steve, Allen K. Chen, Xiaoli Chen, et al.. (2009). Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Research. 2(3). 219–230. 166 indexed citations
13.
Selvarasu, Suresh, Dave Siak‐Wei Ow, Sang Yup Lee, et al.. (2008). Characterizing Escherichia coli DH5α growth and metabolism in a complex medium using genome‐scale flux analysis. Biotechnology and Bioengineering. 102(3). 923–934. 47 indexed citations
14.
Ow, Dave Siak‐Wei, Miranda G.S. Yap, & Steve Oh. (2008). Enhancement of plasmid DNA yields during fed‐batch culture of a fruR‐knockout Escherichia coli strain. Biotechnology and Applied Biochemistry. 52(1). 53–59. 13 indexed citations
15.
Ow, Dave Siak‐Wei, Dong‐Yup Lee, Miranda G.S. Yap, & Steve Oh. (2008). Identification of cellular objective for elucidating the physiological state of plasmid‐bearing Escherichia coli using genome‐scale in silico analysis. Biotechnology Progress. 25(1). 61–67. 30 indexed citations
16.
Choo, Andre, Heng Liang Tan, Wey Jia Fong, et al.. (2008). Selection Against Undifferentiated Human Embryonic Stem Cells by a Cytotoxic Antibody Recognizing Podocalyxin-Like Protein-1. Stem Cells. 26(6). 1454–1463. 208 indexed citations
17.
Chen, Stephen, Andre Choo, Angela Chin, & Steve Oh. (2006). TGF-β2 allows pluripotent human embryonic stem cell proliferation on E6/E7 immortalized mouse embryonic fibroblasts. Journal of Biotechnology. 122(3). 341–361. 17 indexed citations
18.
Oh, Steve, Wey Jia Fong, Heng Liang Tan, et al.. (2005). High density cultures of embryonic stem cells. Biotechnology and Bioengineering. 91(5). 523–533. 38 indexed citations
19.
Choo, Andre, Jayanthi Padmanabhan, Angela Chin, & Steve Oh. (2004). Expansion of pluripotent human embryonic stem cells on human feeders. Biotechnology and Bioengineering. 88(3). 321–331. 57 indexed citations
20.
Tan, Heng Liang, et al.. (2004). Assessment of Stem Cell Markers During Long-Term Culture of Mouse Embryonic Stem Cells. Cytotechnology. 44(1-2). 77–91. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zijun Zhang Breakdown of academic impact, for papers by Haishuang Lin Breakdown of academic impact, for papers by Rumi Sawada Breakdown of academic impact, for papers by Benjamin E. Mead Breakdown of academic impact, for papers by Briana R. Dye Breakdown of academic impact, for papers by Calvin C. Sheng Breakdown of academic impact, for papers by Chukwuma A. Agu Breakdown of academic impact, for papers by Iwona Grabowska Breakdown of academic impact, for papers by Daniel W. Youngstrom Breakdown of academic impact, for papers by Maryam Niapour
Rankless by CCL
2026